Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 15 of 15 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/12
End: 03/06/16
Due: 03/06/17
Phase: N/A
Priority: Normal
Start: 05/31/16
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/31/14
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 07/31/17
End: 07/31/18
Due: 07/31/19
Phase: N/A
Priority: Normal
Start: 12/31/15
End: 02/29/16
Due: 02/28/17
Phase: N/A
Priority: Normal
Start: 03/31/13
End: 03/31/14
Due: 03/31/15
Phase: N/A
Priority: Normal
Start: 06/30/16
End: 07/31/22
Due: 07/31/23
Phase: N/A
Priority: Normal
Start: 11/30/05
End: 01/31/06
Due: 01/31/07
Phase: N/A
Priority: Normal
Start: 07/10/17
End: 08/01/20
Due: 08/01/21
An Open-Label, Dose Escalation Study to Evaluate the Safety and the Pharmacokinetics of Oral PRX-112
Phase: N/A
Priority: Normal
Start: 04/30/14
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 01/16/14
End: 11/09/21
Due: 11/09/22
Phase: N/A
Priority: Normal
Start: 05/17/17
End: 01/09/20
Due: 01/09/21
Phase: N/A
Priority: Normal
Start: 03/23/23
End: 02/06/25
Due: 02/06/26
Phase: N/A
Priority: Normal
Start: 09/30/16
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/10
End: 08/31/10
Due: 08/31/11